Share on StockTwits

Imperva (NASDAQ:IMPV) has received a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the stock, Stock Ratings Network reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $41.85.

Shares of Imperva (NASDAQ:IMPV) opened at 22.81 on Wednesday. Imperva has a 52-week low of $18.40 and a 52-week high of $67.12. The stock’s 50-day moving average is $24.62 and its 200-day moving average is $45.41. The company’s market cap is $599.9 million.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Thursday, May 1st. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.05. The company had revenue of $31.50 million for the quarter, compared to the consensus estimate of $31.73 million. During the same quarter in the previous year, the company posted ($0.13) earnings per share. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, analysts predict that Imperva will post $-1.14 earnings per share for the current fiscal year.

In other Imperva news, VP Ralph Pisani sold 8,613 shares of Imperva stock in a transaction that occurred on Friday, May 23rd. The shares were sold at an average price of $21.31, for a total value of $183,543.03. The transaction was disclosed in a filing with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at RBC Capital cut their price target on shares of Imperva from $50.00 to $33.00 in a research note on Wednesday, May 7th. They now have an “outperform” rating on the stock. Separately, analysts at Imperial Capital cut their price target on shares of Imperva from $40.00 to $34.00 in a research note on Monday, May 5th. They now have an “outperform” rating on the stock. Finally, analysts at Pacific Crest cut their price target on shares of Imperva from $48.00 to $35.00 in a research note on Friday, May 2nd.

Imperva, Inc (NASDAQ:IMPV) is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.